Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,969.50
-0.60 (-0.03%)
At close: Sep 11, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 499.42 billion as of September 14, 2026. Its market cap has increased by 49.92% in one year.
Market Cap
499.42B
Enterprise Value
510.15B
Revenue
101.26B
Ranking
n/a
PE Ratio
38.13
Stock Price
1,969.50
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 499.42B, an increase of 15,415.86%. That is a compound annual growth rate of 23.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 499.42B | 38.73% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.89T |
| Dr. Reddy's Laboratories | 967.09B |
| Lupin | 958.36B |
| Abbott India | 543.69B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |